Post-marketing surveillance of administration of botulinum toxin type B(NerBloc )-Investigation of the clinical condition and safety in patients with cervical dystonia (Study NB01S)

Trial Profile

Post-marketing surveillance of administration of botulinum toxin type B(NerBloc )-Investigation of the clinical condition and safety in patients with cervical dystonia (Study NB01S)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 01 Mar 2017

At a glance

  • Drugs Botulinum toxin B (Primary)
  • Indications Torticollis
  • Focus Therapeutic Use
  • Sponsors Eisai Co Ltd
  • Most Recent Events

    • 30 Jun 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top